Clinical Trials Directory

Trials / Unknown

UnknownNCT05932719

Multicentric Evaluation of COVID-19 Impact on Cancer Patients' Diagnostic and Management: Set-up of Indicators

Multicentric Evaluation of COVID-19 Impact on Cancer Patients' Diagnostic and Management: Set-up of Indicators to Follow-up the Activities of Different Cancer Pathologies

Status
Unknown
Phase
Study type
Observational
Enrollment
4,000 (estimated)
Sponsor
Hospices Civils de Lyon · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The COVID-19 pandemic has deeply and globally impacted usual procedures and patients management in cancer centers. The aim of this study is to set-up and collect indicators to follow-up the activities of different cancer pathologies before and during the pandemic. Patients loss' of chance will be analysed in term of diagnosis and access to care (surgery, antineoplastic treatments). Data collection will focus on the analysis of 2 specific pathologies for French patients in the "Auvergne-Rhône Alpes" Area: peritoneal carcinosis and hepatocellular carcinoma.

Conditions

Interventions

TypeNameDescription
OTHERCOLLAT-COVID is an observational study based on retrospective data issued from patients medial files.The following items will be collected * Diagnostic date * Diagnostic stage * Date of surgery * Date of surgery appointment * First antineoplastic treatment date * Last antineoplastic treatment date * Number of treatment cycles recommanded by MDTM

Timeline

Start date
2022-12-01
Primary completion
2022-12-01
Completion
2024-12-01
First posted
2023-07-06
Last updated
2023-07-10

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT05932719. Inclusion in this directory is not an endorsement.